Securing retatrutide in the United States currently presents a difficulty as it's not yet approved for widespread public distribution . Clinicians participating in investigational studies may be dispensing it, but access is limited to those enrolled. Specialized dispensaries, operating under specific licenses , *might* offer compounded versions,… Read More